1974 related articles for article (PubMed ID: 27481308)
41. Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland.
Guilcher K; Fournier N; Schoepfer A; Schibli S; Spalinger J; Braegger C; Nydegger A;
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1159-1167. PubMed ID: 29985208
[TBL] [Abstract][Full Text] [Related]
42. Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011.
Moller FT; Andersen V; Wohlfahrt J; Jess T
Am J Gastroenterol; 2015 Apr; 110(4):564-71. PubMed ID: 25803400
[TBL] [Abstract][Full Text] [Related]
43. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
[TBL] [Abstract][Full Text] [Related]
44. Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study.
Everhov ÅH; Erichsen R; Järås J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT; Olén O
Aliment Pharmacol Ther; 2022 Oct; 56(7):1168-1182. PubMed ID: 35916190
[TBL] [Abstract][Full Text] [Related]
45. Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease.
Pozler O; Maly J; Bonova O; Dedek P; Frühauf P; Havlickova A; Janatova T; Jimramovsky F; Klimova L; Klusacek D; Kocourkova D; Kolek A; Kotalova R; Marx D; Nevoral J; Petro R; Petru O; Plasilova I; Seidl Z; Sekyrova I; Semendak N; Schreierova I; Stanek J; Sykora J; Sulakova A; Toukalkova L; Travnickova R; Volf V; Zahradnicek L; Zenisková I
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):186-9. PubMed ID: 16456413
[TBL] [Abstract][Full Text] [Related]
46. Increased risk of genital warts in inflammatory bowel disease: A Danish registry-based cohort study (1996-2018).
Elmahdi R; Thomsen LT; Iversen AT; Allin KH; Kjaer SK; Jess T
United European Gastroenterol J; 2022 Apr; 10(3):287-295. PubMed ID: 35297191
[TBL] [Abstract][Full Text] [Related]
47. Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea.
Hong SN; Kim HJ; Kim KH; Han SJ; Ahn IM; Ahn HS
Aliment Pharmacol Ther; 2017 Jan; 45(2):253-263. PubMed ID: 27933686
[TBL] [Abstract][Full Text] [Related]
48. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
49. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
50. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
[TBL] [Abstract][Full Text] [Related]
51. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
52. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
[TBL] [Abstract][Full Text] [Related]
53. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease.
Lopez A; Mounier M; Bouvier AM; Carrat F; Maynadié M; Beaugerie L; Peyrin-Biroulet L;
Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1324-9. PubMed ID: 24582568
[TBL] [Abstract][Full Text] [Related]
54. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM
Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159
[TBL] [Abstract][Full Text] [Related]
55. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
Korzenik J; Larsen MD; Nielsen J; Kjeldsen J; Nørgård BM
Aliment Pharmacol Ther; 2019 Aug; 50(3):289-294. PubMed ID: 31267570
[TBL] [Abstract][Full Text] [Related]
56. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
Karmiris K; Bossuyt P; Sorrentino D; Moreels T; Scarcelli A; Legido J; Dotan I; Naismith GD; Jussila A; Preiss JC; Kruis W; Li AC; Bouguen G; Yanai H; Steinwurz F; Katsanos KH; Subramaniam K; Tarabar D; Zaganas IV; Ben-Horin S;
J Crohns Colitis; 2015 May; 9(5):382-9. PubMed ID: 25740813
[TBL] [Abstract][Full Text] [Related]
57. Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development.
Hammer T; Lophaven SN; Nielsen KR; von Euler-Chelpin M; Weihe P; Munkholm P; Burisch J; Lynge E
Aliment Pharmacol Ther; 2017 Apr; 45(8):1107-1114. PubMed ID: 28176348
[TBL] [Abstract][Full Text] [Related]
58. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
59. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe.
Lakatos PL; Lovasz BD; David G; Pandur T; Erdelyi Z; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Golovics PA; Vegh Z; Mandel M; Horvath A; Szathmari M; Kiss LS; Lakatos L
J Crohns Colitis; 2013 Jun; 7(5):385-91. PubMed ID: 22766526
[TBL] [Abstract][Full Text] [Related]
60. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
